Skip to main content
. 2018 May 18;18(2):135–147. doi: 10.3727/105221618X15174108894682

Figure 4.

Figure 4

EMD1214063 inhibits c-MET signaling in the Met-β-catenin hepatocellular carcinoma (HCC) mouse model. Western blot analysis using whole-liver lysates from control- and EMD1214063-treated groups at 8 and 11 weeks shows a notable decrease in the levels of p-Met (Tyr1234/1235), p-ERK1/2 (Thr202/Tyr204), p-AKT (Ser473), and p-STAT3 (Tyr705) levels in the EMD1214063-treated group. GAPDH shows comparable loading in all lanes.